• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外阴癌的多模态影像学:分期、治疗反应和并发症。

Multimodality imaging of vulvar cancer: staging, therapeutic response, and complications.

机构信息

Department of Diagnostic Imaging, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1473, Houston, TX 77030, USA.

出版信息

AJR Am J Roentgenol. 2013 Jun;200(6):1387-400. doi: 10.2214/AJR.12.9714.

DOI:10.2214/AJR.12.9714
PMID:23701080
Abstract

OBJECTIVE

Vulvar carcinoma is a rare malignancy, most commonly seen in elderly women. Survival depends on the lymph node status. Lymph node-negative patients have a 5-year survival of 90%, whereas survival drops to about 50% in patients with positive lymph nodes. The purpose of this article is to familiarize the reader with the revised International Federation of Gynecology and Obstetrics (FIGO) staging of vulvar cancer and incorporate it into daily practice when interpreting cross-sectional imaging studies.

CONCLUSION

Although vulvar cancer is diagnosed clinically, cross-sectional imaging plays an important complimentary role in staging of the tumor, assessing extent of disease, and selecting operable versus inoperable candidates to ultimately help in decreasing morbidity and increasing survival in these patients.

摘要

目的

外阴癌是一种罕见的恶性肿瘤,最常见于老年女性。生存率取决于淋巴结状态。淋巴结阴性患者的 5 年生存率为 90%,而淋巴结阳性患者的生存率下降至约 50%。本文旨在使读者熟悉修订后的国际妇产科联合会(FIGO)外阴癌分期,并在解读横断面影像学研究时将其纳入日常实践。

结论

尽管外阴癌是通过临床诊断的,但横断面成像在外阴肿瘤分期、评估疾病范围以及选择可手术与不可手术患者方面发挥着重要的补充作用,最终有助于降低这些患者的发病率并提高生存率。

相似文献

1
Multimodality imaging of vulvar cancer: staging, therapeutic response, and complications.外阴癌的多模态影像学:分期、治疗反应和并发症。
AJR Am J Roentgenol. 2013 Jun;200(6):1387-400. doi: 10.2214/AJR.12.9714.
2
Comparison of clinical versus surgical staging systems in vulvar cancer.外阴癌临床分期系统与手术分期系统的比较。
Obstet Gynecol. 1992 Dec;80(6):927-30.
3
Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.FIGO 2009 外阴癌分期分类对预后和分期分布的影响。
Gynecol Oncol. 2012 Oct;127(1):147-52. doi: 10.1016/j.ygyno.2012.06.005. Epub 2012 Jun 13.
4
[Effectiveness of radical therapy in vulvar carcinoma. An analysis of 148 cases].[外阴癌根治性治疗的有效性。148例分析]
Zentralbl Gynakol. 1997;119(4):166-72.
5
The accuracy of magnetic resonance imaging in staging of vulvar cancer: a retrospective multi-centre study.磁共振成像在外阴癌分期中的准确性:一项回顾性多中心研究。
Gynecol Oncol. 2010 Apr;117(1):82-7. doi: 10.1016/j.ygyno.2009.12.017. Epub 2010 Jan 21.
6
[Clinical significance of the revised international federation of gynecology and obstetrics staging system 2009].[2009年修订的国际妇产科联盟分期系统的临床意义]
Zhonghua Fu Chan Ke Za Zhi. 2010 Oct;45(10):721-4.
7
Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.外阴鳞状细胞癌。根治性整块外阴切除术及双侧腹股沟淋巴结清扫术后局部复发的预后因素。
J Reprod Med. 2000 Aug;45(8):672-8.
8
[Explanations and discussions of the revised international federation of gynecology and obstetrics staging system 2009].[2009年国际妇产科联盟修订分期系统的解释与讨论]
Zhonghua Fu Chan Ke Za Zhi. 2010 Oct;45(10):725-31.
9
The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysis.国际妇产科联盟(FIGO)分期在外阴癌患者中的预后作用:一项系统评价和荟萃分析。
Curr Med Res Opin. 2016 Jun;32(6):1121-30. doi: 10.1185/03007995.2016.1162147. Epub 2016 Apr 5.
10
Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease?在淋巴结阴性外阴癌患者中,切除的淋巴结数量是否会影响生存?
Gynecol Oncol. 2010 May;117(2):308-11. doi: 10.1016/j.ygyno.2010.01.007. Epub 2010 Feb 13.

引用本文的文献

1
Cancer of the vulva: 2025 update: FIGO Cancer Report 2025.外阴癌:2025年更新:国际妇产科联盟(FIGO)2025年癌症报告
Int J Gynaecol Obstet. 2025 Sep;171 Suppl 1(Suppl 1):36-47. doi: 10.1002/ijgo.70390. Epub 2025 Jul 30.
2
MRI in the Evaluation of Locally Advanced Vulvar Cancer Treated with Chemoradiotherapy and Vulvar Cancer Recurrence: The 2021 Revision of FIGO Classification and the Need for Multidisciplinary Management.MRI在评估接受放化疗的局部晚期外阴癌及外阴癌复发中的应用:2021年FIGO分类修订版及多学科管理的必要性
Cancers (Basel). 2022 Aug 9;14(16):3852. doi: 10.3390/cancers14163852.
3
Vulvar Cancer: 2021 Revised FIGO Staging System and the Role of Imaging.
外阴癌:2021年修订的国际妇产科联盟(FIGO)分期系统及影像学的作用
Cancers (Basel). 2022 Apr 30;14(9):2264. doi: 10.3390/cancers14092264.
4
MRI Staging in Locally Advanced Vulvar Cancer: From Anatomy to Clinico-Radiological Findings. A Multidisciplinary VulCan Team Point of View.局部晚期外阴癌的MRI分期:从解剖结构到临床放射学表现。多学科外阴癌团队观点。
J Pers Med. 2021 Nov 18;11(11):1219. doi: 10.3390/jpm11111219.
5
Cancer of the vulva: 2021 update.外阴癌:2021 年更新。
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):7-18. doi: 10.1002/ijgo.13881.
6
Vulvar cancer staging: guidelines of the European Society of Urogenital Radiology (ESUR).外阴癌分期:欧洲泌尿生殖放射学会(ESUR)指南
Insights Imaging. 2021 Sep 22;12(1):131. doi: 10.1186/s13244-021-01075-6.
7
Factors influencing the use of adaptive radiation therapy in vulvar carcinoma.影响外阴癌中自适应放射治疗应用的因素。
Rep Pract Oncol Radiother. 2020 Sep-Oct;25(5):709-713. doi: 10.1016/j.rpor.2020.06.005. Epub 2020 Jul 10.
8
Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT.在 COVID-19 时代实现外阴癌工作流程的个体化:来自外阴癌多学科治疗团队的建议。
J Cancer Res Clin Oncol. 2020 Oct;146(10):2535-2545. doi: 10.1007/s00432-020-03312-9. Epub 2020 Jul 12.
9
An Overview of Vulvar Cancer: A Single-Center Study from Northeast India.外阴癌概述:来自印度东北部的一项单中心研究
J Obstet Gynaecol India. 2019 Dec;69(6):541-545. doi: 10.1007/s13224-019-01261-z. Epub 2019 Aug 16.
10
State of the art in vulvar cancer imaging.外阴癌成像的最新技术水平。
Radiol Bras. 2019 Sep-Oct;52(5):316-324. doi: 10.1590/0100-3984.2018.0072.